Skip to main navigation
  • Investors
    • Overview
    • News & Events
    • Stock
    • Corporate Governance
    • Financial Information
    • Shareholder Services
  • Careers
  • Contact Us
Veradermics, Inc. corp site
  • About Us
    • Overview
    • Our Team
    • Board of Directors
  • Our Approach
  • Our Pipeline
    • Overview
    • Pattern Hair Loss
  • About VDPHL01
  • Clinical Trials
  • About Us
    • Overview
    • Our Team
    • Board of Directors
  • Our Approach
  • Our Pipeline
    • Overview
    • Pattern Hair Loss
  • About VDPHL01
  • Clinical Trials
  • Investors
    • Overview
    • News & Events
      • News Releases
      • Events
      • Presentations
    • Stock
    • Corporate Governance
      • Documents & Charters
      • Board of Directors
      • Management Team
      • Committee Composition
    • Financial Information
    • Shareholder Services
      • Investor FAQs
      • Email Alerts
      • Information Request
  • Careers
  • Contact Us

News Releases

  • Overview
  • News & Events
  • Stock
  • Corporate Governance
  • Financial Information
  • Shareholder Services
  • News Releases
  • Events
  • Presentations

March 18, 2026

Veradermics Announces Presentations on VDPHL01 and Patient Experiences With Pattern Hair Loss at 2026 American Academy of Dermatology Annual Meeting

March 3, 2026

Veradermics to Participate in Upcoming March Investor Conferences

February 9, 2026

Veradermics Completes Enrollment in Second Pivotal Phase 3 Clinical Trial of VDPHL01 for Male Pattern Hair Loss

February 5, 2026

Veradermics Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering

February 3, 2026

Veradermics Announces Pricing of Upsized Initial Public Offering
Veradermics, Inc. footer logo

470 James St., Suite 14
New Haven, CT 06513

 

+1.22.VERA.DERM
(+1.228.372.3376)

twitter twitter twitter
  • About Us
  • Our Approach
  • Our Pipeline
  • Clinical Trials
  • Investors
  • Careers
  • Contact Us

Veradermics is on a mission to make long-ignored dermatology and aesthetics conditions simple — replacing false hope, confusion, and questionable results with solutions that people and providers can trust.

© 2026 Veradermics, Inc. All Rights Reserved .

  • Terms of Use
  • Privacy Policy
  • Washington State Privacy